Cargando…
Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies
BACKGROUND: Numerous vaccination research experiments have been conducted on non-primate hosts to prevent or control HTLV-1 infection. Therefore, reviewing recent advancements for status assessment and strategic planning of future preventative actions to reduce HTLV-1 infection and its consequences...
Autores principales: | Seighali, Niloofar, Shafiee, Arman, Rafiee, Mohammad Ali, Aminzade, Dlnya, Mozhgani, Sayed-Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173209/ https://www.ncbi.nlm.nih.gov/pubmed/37170214 http://dx.doi.org/10.1186/s12879-023-08289-7 |
Ejemplares similares
-
Comparison of COVID-19 outcomes in patients with Type 1 and Type 2 diabetes: A systematic review and meta-analysis
por: Shafiee, Arman, et al.
Publicado: (2022) -
The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways
por: Yaslianifard, Sahar, et al.
Publicado: (2023) -
Seroepidemiology of Human T-Cell Lymphotropic Virus Type-1 (HTLV1) in Mashhad
por: Safabakhsh, Hamidreza, et al.
Publicado: (2014) -
Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis
por: Shafiee, Arman, et al.
Publicado: (2023) -
Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1)
por: Raza, Md. Thosif, et al.
Publicado: (2021)